Pharmacokinetics: optimising safe and effective prescribing

@article{Mayor2017PharmacokineticsOS,
  title={Pharmacokinetics: optimising safe and effective prescribing},
  author={Susan Mayor},
  journal={Prescriber},
  year={2017},
  volume={28}
}
  • S. Mayor
  • Published 1 March 2017
  • Medicine
  • Prescriber
This article goes back to basics with an update on pharmacokinetics, examining how underlying processes in the body influence the clinical effects and risk of side‐effects of drugs that GPs commonly prescribe. 
1 Citations
Optimising the absorption of medicines.
  • Jodie Coulson
  • Medicine
    Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • 2020
TLDR
The pharmacokinetic factors that affect medicine absorption are discussed and the four principles of medicines optimisation are examined and how nurses can use these to ensure the safe and effective use of medicines.

References

SHOWING 1-4 OF 4 REFERENCES
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
TLDR
Although genotype tests can determine if a patient has a specific enzyme polymorphism, it has not been determined if routine use of these tests will improve outcomes and knowledge of the most important drugs metabolized by cytochrome P450 enzymes, as well as the most potent inhibiting and inducing drugs, can help minimize the possibility of adverse drug reactions and interactions.
High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice
TLDR
The prevalence and patterns of high risk prescribing, defined as potentially inappropriate prescribing of drugs to primary care patients particularly vulnerable to adverse drug events, were examined in general practices in Scotland.
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
TLDR
The burden ofADRs on the NHS is high, accounting for considerable morbidity, mortality, and extra costs, and measures need to be put into place to reduce the burden of ADRs and thereby further improve the benefit:harm ratio of the drugs.